<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Inflammatory processes have been implicated in the pathogenesis of brain damage after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In rodent <z:hpo ids='HP_0001297'>stroke</z:hpo> models, focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> induces several proinflammatory chemokines, including monocyte chemoattractant protein-1 (<z:chebi fb="17" ids="50099">MCP</z:chebi>-1) </plain></SENT>
<SENT sid="2" pm="."><plain>The individual contribution to ischemic tissue damage, however, is largely unknown </plain></SENT>
<SENT sid="3" pm="."><plain>To address this question, the authors subjected <z:chebi fb="17" ids="50099">MCP</z:chebi>-1-deficient mice (<z:chebi fb="17" ids="50099">MCP</z:chebi>-1-/-) to permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="4" pm="."><plain>Measurement of basal blood pressure, cerebral blood flow, and blood volume revealed no differences between <z:mp ids='MP_0002169'>wild-type</z:mp> (wt) and <z:chebi fb="17" ids="50099">MCP</z:chebi>-1-/- mice </plain></SENT>
<SENT sid="5" pm="."><plain>MCAO led to similar cerebral perfusion deficits in wt and <z:chebi fb="17" ids="50099">MCP</z:chebi>-1-/- mice, excluding differences in the <z:chebi fb="70" ids="34342">MCA</z:chebi> supply territory and collaterals </plain></SENT>
<SENT sid="6" pm="."><plain>However, compared with wt mice, the mean <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was 29% smaller in <z:chebi fb="17" ids="50099">MCP</z:chebi>-1-/- mice 24 hours after MCAO (P = 0.022) </plain></SENT>
<SENT sid="7" pm="."><plain>Immunostaining showed a reduction of phagocytic macrophage accumulation within <z:mpath ids='MPATH_124'>infarcts</z:mpath> and the <z:mpath ids='MPATH_124'>infarct</z:mpath> border in <z:chebi fb="17" ids="50099">MCP</z:chebi>-1-/- mice 2 weeks after MCAO </plain></SENT>
<SENT sid="8" pm="."><plain>At the same time point, the authors found an attenuation of astrocytic <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> in the <z:mpath ids='MPATH_124'>infarct</z:mpath> border and thalamus in <z:chebi fb="17" ids="50099">MCP</z:chebi>-1-/- mice </plain></SENT>
<SENT sid="9" pm="."><plain>However, these effects on macrophages and astrocytes in <z:chebi fb="17" ids="50099">MCP</z:chebi>-1-/- mice occurred too late to suggest a protective role in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_124'>infarct</z:mpath> growth </plain></SENT>
<SENT sid="10" pm="."><plain>Of note: at 6 hours after MCAO, <z:chebi fb="17" ids="50099">MCP</z:chebi>-1-/- mice produced significantly less interleukin-1beta in ischemic tissue; this might be related to tissue protection </plain></SENT>
<SENT sid="11" pm="."><plain>The results of this study indicate that inhibition of <z:chebi fb="17" ids="50099">MCP</z:chebi>-1 signaling could be a new <z:hpo ids='HP_0011009'>acute</z:hpo> treatment approach to limit <z:mpath ids='MPATH_124'>infarct</z:mpath> size after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>